Analyst II, Business Control Function SOX Tester at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Exceptional expertise in financial and operational controls
Deep understanding of the business landscape, market trends, and industry dynamics
Outstanding ability to forge strong partnerships across the organization to provide insights and guidance to cross-functional teams
Open communication and cooperation to ensure BCF activities are executed seamlessly
Excellent leadership skills, inspiring and motivating team members to deliver exceptional results
Minimum of 3-5 years of experience
Based in BMS’s Hyderabad Location (expected 50% in-person)

Responsibilities

Performs SOX controls testing, providing timely, effective, and prompt SOX testing results
Identifies and assesses financial, operational, and compliance risks to accuracy of financial reporting
Evaluates design and operating effectiveness of key controls related to financial reporting
Maintains accurate and well-organized documentation of testing procedures, results, and supporting evidence
Delivers regular reports on SOX testing status to the Associate Director, BCF Hyderabad Lead, for consumption by BCF Executive Director, AD of SOX Methodology & Program Governance, and Leadership team
Assists in the development of internal control enhancements, both proactively and in response to internal control deficiencies identified
Actively influences the identification of continuous improvement opportunities in the SOX testing processes
Holds self and others to timelines, quality, and accuracy
Articulates material risks and opportunities and takes an active role in designing and executing response or contingency plans

Skills

SOX

financial controls

operational controls

business controls

leadership

cross-functional collaboration

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free